Opportunity or Challenge June 14 2022

Source – Nature Briefing

Researchers fear that development of new treatments for COVID-19 could falter as the clinical trials needed to test them become increasingly difficult. In many places, vaccinations have led to a decline in severe disease, shrinking the pool of potential study participants. Hesitance to enrol in trials is rising, and the existence of potent treatments is making statistical analysis more difficult. But new treatments are needed: current options can be expensive and limited in supply, and some strains of SARS-CoV-2 could become resistant to them.

Nature | 6 min read

Given the past 2 years of RVX struggles this bit of information will be a boon for Don's excuse mill. The last sentence gives me hope.

GLTA

Toinv